-
Investors Are Watching: Pitney Bowes Inc. (NYSE:PBI), Atmel Corporation (NASDAQ:ATML), Cardinal Health (NYSE:CAH), Northern Dynasty Minerals (NYSEMKT:NAK), Biota Pharmaceuticals (NASDAQ:BOTA)
Pitney Bowes Inc. (NYSE:PBI) Chief Executive Marc B. Lautenbach said Tuesday he expects flat or reduced employment levels next year as the mail and document-services company cuts costs further as it adapts to the digital era. Pitney Bowes Inc. (NYSE:PBI) in last trading activity advanced 4.77% to close at $25.24. Company weekly performance is -0.16%…
-
Trending Stocks: Altria Group Inc. (NYSE:MO), Yandex N.V. (NASDAQ:YNDX), Franklin Resources Inc. (NYSE:BEN), Global Ship Lease (NYSE:GSL), Biota Pharmaceuticals (NASDAQ:BOTA)
Altria Group (NYSE:MO) EVP John R. Nelson sold 1,640 shares of Altria Group stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $49.06, for a total value of $80,458.40. Following the sale, the executive vice president now directly owns 407,288 shares of the company’s stock,…
-
Investors Watch List: Plains All American Pipeline (NYSE:PAA), Net Element International (NASDAQ:NETE), Ever-Glory International (NYSEMKT:EVK), Biota Pharmaceuticals (NASDAQ:BOTA), Tesla Motors Inc (NASDAQ:TSLA)
Plains All American Pipeline, L.P. (NYSE:PAA) EVP John R. Rutherford sold 8,225 shares of Plains All American Pipeline, L.P. stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $53.70, for a total value of $441,682.50. Following the sale, the executive vice president now directly owns 60,800 shares…
-
Hot Watch List: Aldeyra Therapeutics (NASDAQ:ALDX), Wells Fargo & Company (NYSE:WFC), Prologis (NYSE:PLD), Biota Pharmaceuticals (NASDAQ:BOTA), IberiaBank Corp. (NASDAQ:IBKC)
For the third quarter of 2014, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) reported net losses attributable to common stockholders of approximately $2.0 million compared to net income of approximately $878,000 for the third quarter of 2013. Basic and diluted net loss per share was $0.36 for the three months ended September 30, 2014 compared to basic net…
-
Watch List: Biota Pharmaceuticals (NASDAQ:BOTA), Dicerna Pharmaceuticals (NASDAQ:DRNA), Tessera Technologies Inc. (NASDAQ:TSRA), Apple Inc. (NASDAQ:AAPL), Vodafone Group Plc (ADR) (NASDAQ:VOD)
On November 7, Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) announced its financial results for the three month period ended September 30, 2014. The Company reported a net loss of $6.9 million for the three month period ended September 30, 2014, as compared to a net loss of $3.9 million in the same period of 2013. The $3.0…
-
Top Wall Street Stories: Biota Pharmaceuticals (NASDAQ:BOTA), Rite Aid Corporation (NYSE:RAD), Astea International (NASDAQ:ATEA), Parker-Hannifin (NYSE:PH), Global Brass and Copper (NYSE:BRSS)
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced that management will host a conference call on Friday, November 7, 2014 at 9:00 a.m. EST to review the Company’s first quarter financial results and provide an update on recent corporate developments. Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) in last trading activity moved down -2.10% to close at $2.33. Company weekly performance…